177 related articles for article (PubMed ID: 8841514)
1. Overexpression of copper-zinc superoxide dismutase in trisomy 21.
De La Torre R; Casado A; López-Fernández E; Carrascosa D; Ramírez V; Sáez J
Experientia; 1996 Sep; 52(9):871-3. PubMed ID: 8841514
[TBL] [Abstract][Full Text] [Related]
2. Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: models for the study of free radical metabolism and aging.
Ceballos-Picot I; Nicole A; Sinet PM
EXS; 1992; 62():89-98. PubMed ID: 1450608
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down's syndrome.
Meguid NA; Kholoussi NM; Afifi HH
Biol Trace Elem Res; 2001 Jul; 81(1):21-8. PubMed ID: 11508329
[TBL] [Abstract][Full Text] [Related]
4. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
6. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
7. Atypical Down syndrome and partial trisomy 21.
Jenkins EC; Duncan CJ; Wright CE; Giordano FM; Wilbur L; Wisniewski K; Sklower SL; French JH; Jones C; Brown WT
Clin Genet; 1983 Aug; 24(2):97-102. PubMed ID: 6225574
[TBL] [Abstract][Full Text] [Related]
8. A boy with Down's syndrome having recombinant chromosome 21 but no SOD-1 excess.
Miyazaki K; Yamanaka T; Ogasawara N
Clin Genet; 1987 Dec; 32(6):383-7. PubMed ID: 2963715
[TBL] [Abstract][Full Text] [Related]
9. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
Gulesserian T; Seidl R; Hardmeier R; Cairns N; Lubec G
J Investig Med; 2001 Jan; 49(1):41-6. PubMed ID: 11217146
[TBL] [Abstract][Full Text] [Related]
10. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
Ceballos-Picot I
C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
[TBL] [Abstract][Full Text] [Related]
11. Copper/zinc superoxide dismutase (SOD-1) activity in regular trisomy 21, trisomy 21 by translocation and mosaic trisomy 21.
Jeziorowska A; Jakubowski L; Armatys A; Kałuzewski B
Clin Genet; 1982 Oct; 22(4):160-4. PubMed ID: 6217928
[No Abstract] [Full Text] [Related]
12. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactive copper-zinc superoxide-dismutase (SOD-1) in mosaic trisomy 21 and normal subjects.
Baeteman MA; Mattei MG; Baret A; Mattei JF
Acta Paediatr Scand; 1984 May; 73(3):341-4. PubMed ID: 6234750
[TBL] [Abstract][Full Text] [Related]
14. Radiation sensitivity of Down's syndrome fibroblasts might be due to overexpressed Cu/Zn-superoxide dismutase (EC 1.15.1.1).
Schwaiger H; Weirich HG; Brunner P; Rass C; Hirsch-Kauffmann M; Groner Y; Schweiger M
Eur J Cell Biol; 1989 Feb; 48(1):79-87. PubMed ID: 2526018
[TBL] [Abstract][Full Text] [Related]
15. Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome.
Jenkins EC; Schupf N; Genovese M; Ye LL; Kapell D; Canto B; Harris M; Devenny D; Lee JH; Brown WT
Am J Med Genet; 1997 Jan; 68(2):147-51. PubMed ID: 9028448
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
17. Enzymes of leukocyte oxidative metabolism in Down's syndrome.
Björkstén B; Marklund S; Hägglöf B
Acta Paediatr Scand; 1984 Jan; 73(1):97-101. PubMed ID: 6322510
[TBL] [Abstract][Full Text] [Related]
18. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.
Minc-Golomb D; Knobler H; Groner Y
EMBO J; 1991 Aug; 10(8):2119-24. PubMed ID: 1829676
[TBL] [Abstract][Full Text] [Related]
19. Structural variation of chromosome 21 and symptoms of Down's syndrome.
Rethoré MO
Hum Genet Suppl; 1981; 2():173-82. PubMed ID: 6218134
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive Cu-SOD and Mn-SOD in lymphocytes sub-populations from normal and trisomy 21 subjects according to age.
Baeteman MA; Baret A; Courtière A; Rebuffel P; Mattei JF
Life Sci; 1983 Feb; 32(8):895-902. PubMed ID: 6219263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
